| abstract |
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: n n n n n n n n n n or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof wherein W, L, R 3 , R 3a , R 3b and R 4 are defined herein. |